Key result
Systemic vasodilators reduce LV afterload, improving cardiac output and lowering pulmonary venous pressure in refractory HF.
Why the study?
Management of congestive heart failure requires understanding of pathophysiology and therapy, with recent advances focusing on systemic vasodilator drugs to reduce left ventricular afterload in refractory cases.
Answers are grounded in this paper and cite their sources.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Dean T. Mason (1980) conducted a review in Acute and Chronic Congestive Heart Failure. Systemic vasodilator drugs was evaluated. Systemic vasodilator drugs reduce excessive left ventricular afterload, improving lowered cardiac output and decreasing elevated pulmonary venous pressure in patients with refractory heart failure.
Synapse has enriched 10 related papers. Consider them for comparative context: